Search

Displaying results 6531 - 6540 of 8517 in total
  1. Drug

    CGI-1842

    go.drugbank.com/drugs/DB12744
    Investigational

    JI-101 has been used in trials studying the treatment of Cancer, Colon Cancer, Neuroendocrine, Ovarian Cancer, and Advanced Solid Tumors.

  2. Drug

    Mafosfamide

    go.drugbank.com/drugs/DB12083
    Investigational

    Mafosfamide has been used in trials studying the treatment of Lymphoma, Leukemia, Meningeal Neoplasm, and Brain and Central Nervous System Tumors.

  3. Drug

    LCL-161

    go.drugbank.com/drugs/DB12085
    Investigational

    LCL161 has been used in trials studying the treatment of Leukemia, Neoplasms, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.

  4. Drug

    Duligotuzumab

    go.drugbank.com/drugs/DB12142
    Investigational

    Duligotuzumab has been used in trials studying the treatment of Neoplasms, Colorectal Cancer, Head and Neck Cancer, and Epithelial Tumors, Malignant.

  5. Drug

    Usistapide

    go.drugbank.com/drugs/DB12414
    Investigational

    Usistapide has been used in trials studying the treatment of Obesity, Overweight, Metabolic Diseases, Nutrition Disorders, and Nutritional and Metabolic Diseases.

  6. Drug

    Bococizumab

    go.drugbank.com/drugs/DB12456
    Investigational

    Bococizumab has been used in trials studying the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.

  7. Drug

    Mubritinib

    go.drugbank.com/drugs/DB12682
    Investigational

    Mubritinib has been used in trials studying the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.

  8. Drug

    Ecopipam

    go.drugbank.com/drugs/DB12273
    Investigational

    Ecopipam has been used in trials studying the treatment of Tourette's Syndrome, Lesch-Nyhan Disease, Pathological Gambling, and Self-injurious Behavior.

  9. Drug

    Iodocetylic acid I-123

    go.drugbank.com/drugs/DB19593
    Experimental

    Iodocetylic acid I-123 has a monoisotopic molecular weight of 378.14 Da.

  10. Drug

    Gliclazide

    go.drugbank.com/drugs/DB01120
    ApprovedInvestigational

    It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of … Gliclazide has been shown to decrease fasting plasma glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels (reflective of the last 8-10 weeks of glucose control).

    Products: AS-GLIKLAZ 30 MG MR TABLET